EUVIMEDEUVIMED entdecken
Crossref

ImesAgCl/TBHP Promoted Aqueous Synthesis of Isatin‐Amide Derivatives: Anti‐proliferative, Anti‐Vascular Endothelial Growth Factor Receptor 2, Bioavailability and Molecular Docking Studies

Gade Narmada, T N Lohith, Murali Krishna Thupurani, Siddhartha Marupati, Dharavath Ashok, Thirukovela Narasimha Swamy

Chemistry & Biodiversity · 2026-02 · 23 (2)

DOI: 10.1002/cbdv.202502894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 12.02.2026. Verfasst von Gade Narmada und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Chaitanya (Deemed to Be University), College of Science, King Saud University, Hyderabad, India. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents, Molecular Docking Simulation, Amides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 126 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a worldwide health burden that influences about every geographic location and socioeconomic class. One of the main challenges that remains is the appearance of resistance to cancer therapy. It is found that vascular endothelial growth factor receptor 2 (VEGFR‐2) is overexpressed in a number of tumours. Few FDA approved drugs (such as Sorafenib, Sunitinib, Nintedanib and Cabotanzinib), which target VEGFRs, however, a significant issue with the monotherapy of these agents is drug resistance. Hence, in the present work. Some isatin‐aromatic amides ( 5a–q ) were synthesised via Ag(I)‐NHC/TBHP‐promoted tandem one‐pot oxidative amidation between 3‐((3‐hydroxypropyl)imino)‐1‐methylindolin‐2‐one ( 3 ) and anilines ( 4a–q ) in water as a key approach. The anti‐proliferative activity of amides ( 5a–q ) revealed that compound 5j (50% inhibitory concentration [IC 50 ] =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsMolecular Docking SimulationAmidesIsatinProtein Kinase InhibitorsHumansCell ProliferationStructure-Activity RelationshipDrug Screening Assays, AntitumorBiological AvailabilityMolecular StructureWaterMCF-7 CellsDose-Response Relationship, DrugTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

in silico studiesin vitro anticancer activityin vitro bioavailabilityisatin‐amidesoxidative amidation

Substanzen

Vascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsAmidesIsatinProtein Kinase InhibitorsWaterKDR protein, humanTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, Chaitanya (Deemed to Be University), College of Science, King Saud University, Hyderabad, India.
  • Department of Physics, Government First Grade College, Tumakuru, Karnataka, India.
  • Department of Biotechnology, Chaitanya (Deemed to Be University), Hyderabad, India.
  • Department of Chemistry, Vardhaman College of Engineering (Autonomous), Hyderabad, India.
  • Department of Forensic Science, Chaitanya (Deemed to Be University), Hyderabad, India.

Zitieren

APA

Narmada, G., Lohith, T. N., Thupurani, M. K., Marupati, S., Ashok, D., & Narasimha Swamy, T. (2026). ImesAgCl/TBHP Promoted Aqueous Synthesis of Isatin‐Amide Derivatives: Anti‐proliferative, Anti‐Vascular Endothelial Growth Factor Receptor 2, Bioavailability and Molecular Docking Studies. Chemistry & Biodiversity, 23(2). https://doi.org/10.1002/cbdv.202502894

Vancouver

Narmada G, Lohith TN, Thupurani MK, Marupati S, Ashok D, Narasimha Swamy T. ImesAgCl/TBHP Promoted Aqueous Synthesis of Isatin‐Amide Derivatives: Anti‐proliferative, Anti‐Vascular Endothelial Growth Factor Receptor 2, Bioavailability and Molecular Docking Studies. Chemistry & Biodiversity. 2026;23(2). doi:10.1002/cbdv.202502894

BibTeX
@article{Narmada2026,
  author = {Narmada, Gade and Lohith, T N and Thupurani, Murali Krishna and Marupati, Siddhartha and Ashok, Dharavath and Narasimha Swamy, Thirukovela},
  title = {ImesAgCl/TBHP Promoted Aqueous Synthesis of Isatin‐Amide Derivatives: Anti‐proliferative, Anti‐Vascular Endothelial Growth Factor Receptor 2, Bioavailability and Molecular Docking Studies},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {2},
  doi = {10.1002/cbdv.202502894}
}
Kostenlos starten →